PG
Schedule 13G filing
Principal Global Investors cut its CSTL stake below 5%
Principal Global Investors reported owning 4.9% of Castle Biosciences Inc (CSTL) (1,500,897 shares) in a Schedule 13G filed Oct 29, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 29, 2026
- Source
- Schedule 13G
More CSTL insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.